Medicare Enrolled

Dr. Jorge Pardo, M.D

Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8940 N KENDALL DR STE 802E, Miami, FL 33176
7869241311
In practice since 2007 (19 years)
NPI: 1174658348 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pardo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pardo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pardo

Dr. Jorge Pardo is a neurology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Pardo performed 1,085 Medicare services across 779 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pardo received a total of $32,460 from 92 pharmaceutical and/or device companies across 1474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pardo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 29% volume in FL$ $32,460 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,085
Medicare services
Top 29% in FL for neurology
779
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)333$101$562
Needle measurement of electrical activity in arm or leg muscles, complete study151$82$435
Office visit, established patient, complex (40-54 min)115$149$788
Annual depression screening84$19$77
EEG, extended monitoring76$366$1,914
New patient office visit (45-59 min)61$123$730
Nerve conduction, 9-10 studies60$172$960
New patient office visit, complex (60-74 min)44$174$976
Administration of psychological or neuropsychological test by technician, each additional 30 minutes36$29$155
Punch biopsy, each additional skin growth31$51$265
Testing of autonomic (sympathetic) nervous system function20$103$1,114
Punch biopsy, first skin growth16$108$563
Evaluation of neuropsychological test, first hour12$105$560
Evaluation of neuropsychological test, each additional hour12$81$433
Administration of psychological or neuropsychological test by technician, first 30 minutes12$28$155
Ultrasound of both sides of head and neck blood flow11$159$1,037
Nerve conduction, 11-12 studies11$204$1,116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$32,460
Total received (2018-2024)
Avg $4,637/year across 7 years
Top 11% in FL for neurology
92
Companies
1,474
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,233 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$227 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,241
2023
$6,222
2022
$4,829
2021
$3,529
2020
$2,716
2019
$4,463
2018
$4,459

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$3,420
Amgen Inc.
$2,025
UCB, Inc.
$1,778
Teva Pharmaceuticals USA, Inc.
$1,746
Alexion Pharmaceuticals, Inc.
$1,401
Lilly USA, LLC
$1,334
Biogen, Inc.
$1,202
Neurocrine Biosciences, Inc.
$1,131
Allergan Inc.
$1,046
Novartis Pharmaceuticals Corporation
$988
PFIZER INC.
$956
ACADIA Pharmaceuticals Inc
$870
ARGENX US, INC.
$729
Lundbeck LLC
$604
Neurelis, Inc.
$603
Adamas Pharmaceuticals, Inc.
$598
AbbVie Inc.
$563
Avanir Pharmaceuticals, Inc.
$523
GENZYME CORPORATION
$472
Allergan, Inc.
$444
US WorldMeds, LLC
$436
Supernus Pharmaceuticals, Inc.
$410
IMPEL PHARMACEUTICALS INC.
$383
CSL Behring
$382
SK Life Science, Inc.
$377
Scilex Pharmaceuticals Inc.
$369
Amneal Pharmaceuticals LLC
$368
Acorda Therapeutics, Inc
$363
Sunovion Pharmaceuticals Inc.
$357
Eisai Inc.
$357
Otsuka America Pharmaceutical, Inc.
$290
SCILEX PHARMACEUTICALS INC.
$287
Biohaven Pharmaceutical Holding Company Ltd.
$269
Merz Pharmaceuticals, LLC
$268
Egalet US Inc
$245
Alnylam Pharmaceuticals Inc.
$240
Upsher-Smith Laboratories LLC
$238
Kyowa Kirin, Inc.
$237
MITSUBISHI TANABE PHARMA AMERICA, INC.
$226
EMD Serono, Inc.
$203
Assertio Therapeutics, Inc.
$193
Biohaven Pharmaceuticals, Inc.
$191
Almatica Pharma LLC
$181
Mitsubishi Tanabe Pharma America, Inc.
$171
IDORSIA PHARMACEUTICALS US INC
$149
Akcea Therapeutics, Inc.
$148
Zyla Life Sciences
$148
Azurity Pharmaceuticals, Inc.
$131
AstraZeneca Pharmaceuticals LP
$128
EISAI INC.
$115
Corium, LLC
$113
MDD US Operations, LLC
$112
Avion Pharmaceuticals
$111
GE HEALTHCARE
$106
Impax Laboratories, Inc.
$96
Harmony Biosciences LLC
$93
Bausch Health US, LLC
$92
Averitas Pharma Inc.
$90
Alfasigma USA, Inc.
$81
Takeda Pharmaceuticals U.S.A., Inc.
$77
GRT US Holding, Inc.
$75
Mallinckrodt Hospital Products Inc.
$68
Strongbridge US INC.
$60
Grifols USA, LLC
$59
LivaNova USA, Inc.
$59
Mallinckrodt LLC
$59
Shire North American Group Inc
$55
Bayer HealthCare Pharmaceuticals Inc.
$54
Zyla Life Sciences, Inc.
$51
Aprecia Pharmaceuticals, LLC
$50
Inspire Medical Systems, Inc.
$49
Ipsen Biopharmaceuticals, Inc
$44
GE HealthCare
$43
Promius Pharma LLC
$39
Piramal Imaging Limited
$37
CATALYST PHARMACEUTICALS, INC.
$35
ANI Pharmaceuticals, Inc.
$35
ASSERTIO THERAPEUTICS, Inc.
$30
Currax Pharmaceuticals LLC
$29
Boston Scientific Corporation
$25
Sumitomo Pharma America, Inc.
$23
Vanda Pharmaceuticals Inc.
$23
AQUESTIVE THERAPEUTICS, INC.
$23
Arbor Pharmaceuticals, Inc.
$23
UPSHER-SMITH LABORATORIES LLC
$23
InSightec,Inc
$21
Horizon Therapeutics plc
$21
Jazz Pharmaceuticals Inc.
$19
Vertical Pharmaceuticals, LLC
$17
BANNER LIFE SCIENCES, LLC
$17
ASSERTIO THERAPEUTICS, INC.
$15
Life Molecular Imaging Ltd
$14
Top 3 companies account for 22.3% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · Azstarys · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dhivy · Dysport · EMGALITY · EVUSHELD · Exablate · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LOREEV XR · LORZONE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ongentys · PAXLOVID · PONVORY · PURIFIED CORTROPHIN GEL · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SERTRALINE HCL · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Soliris · Spritam · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · XCOPRI · Xadago · Xeomin · Xyrem · ZAVZPRET · ZEMBRACE SYMTOUCH · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,992 per 100 Medicare services performed
Looking for a neurology in Miami?
Compare neurologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
220
Per 100K population
8.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pardo is a clinical cardiology specialist, with above-average Medicare volume (top 29% in FL), and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pardo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pardo performed 333 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pardo receive payments from pharmaceutical companies?
Yes. Dr. Pardo received a total of $32,460 from 92 companies across 1,474 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pardo's costs compare to other neurologys in Miami?
Dr. Pardo's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pardo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →